VX-509
VX11-509-102
Phase 3 small_molecule completed
Quick answer
VX-509 for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 3 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed